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1. Introduction
To evaluate the accuracy of a diagnostic test, an unbiased estimate for the
test accuracy is preferred. But in order to obtain an unbiased estimator
for the test accuracy, we need to determine the true disease status for each
patient (present or absent) independent of the patient’s test result. The
procedure that establishes the patient’s true disease status is referred to as
a gold standard.
For many diseases, it is difficult or impossible to establish a definitive
diagnosis. A perfect gold standard may not exist or may be too expensive
or impractical to administer. This is especially true for complex clinical
conditions in the usual clinical practice setting. For example, a definitive
diagnosis of myocardial infarction (MI) is difficult to establish for patients
admitted to a hospital for “rule-out MI”. Similarly, the definitive diagnosis
of Alzheimer’s disease cannot be established until a patient has died and
a neuropathological examination is performed. Even when the “definitive”
diagnosis of a well-defined disease, such as an infection by a known agent, can
be performed, it still may require culturing the organism or other detection
procedures, any of which may be subject to laboratory and other errors.
Consequently, in many diagnostic accuracy studies, an imperfect standard
is used to evaluate the test instead. However, when an imperfect standard
is used as if it were a gold standard, the accuracy of the new test is often
either underestimated or overestimated. This type of bias is called imperfect
1
Hosted by The Berkeley Electronic Press
reference standard bias.
Hui and Zhou (1998) reviewed available statistical methods for estimat-
ing the diagnostic accuracy of one or more new tests, with or without an
imperfect standard, when the true disease status is not known for any of
the subjects. As noted in Hui and Zhou (1998), almost all available statis-
tical methods focus on binary tests and are based on mixture latent class
models; and the majority of those methods require the conditional indepen-
dence assumption (CIA). Only few published papers dealt with estimation
of ROC curves of ordinal or continuous scale tests in the absence of a gold
standard. Henkelman, Kay and Bronskill (1990) proposed a maximum likeli-
hood estimation method for the ROC curve of a five-point rating scale using
a multivariate normal mixture latent model. One major limitation of this
approach is that the latent random variables for multiple ordinal-scale tests
are assumed to follow the multivariate normal distribution. In addition, in
a published commentary on this paper, Begg and Metz (1990) pointed out
three serious potential limitations to this method and called for further re-
search into its properties before they could recommend it for general use.
Another paper by Hall and Zhou (2003) proposed a non-parametric esti-
mator for the ROC curves of continuous-scale tests under the conditional
independence assumption when the number of tests is more than two.
In this paper, we will apply the ideas in Hall and Zhou (2003) to esti-
mating ROC curve areas of ordinal-scale tests when the number of tests is
more than two. As shown in Hall and Zhou (2003), without the conditional
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independence assumption the component distributions in a multivariate la-
tent class model are not identifiable non-parametrically. Hence, in this paper
we focus on a non-parametric maximum likelihood (ML) method under the
conditional independence assumption. In Section 2 we present the method in
detail. We show the existence of many local ML estimate solutions under this
model, the global ML estimate has a ”mirror” solution that yields the same
log-likelihood value, and all local ML estimates, including the global ones,
give the same sum of squared residuals. In Section 3 we conduct simulation
studies to assess the finite-sample properties of the proposed ML estima-
tors, and to compare them with parametric models. We apply the proposed
method to a real study in Section 4.
2. A Non-parametric Approach
2.1 Estimation method
Here we consider the situation where each of the N patients is scored on
an ordinal scale from 1 to J on a battery of K tests. Throughout this paper
we will assume that the disease status is unknown for all N patients and will
attempt to estimate the ROC curves for each of the K tests without this
seemingly necessary piece of information.
Let T1, · · · , TK be the responses from K diagnostic tests for a particular
patient whose disease status although unknown is denoted byD, whereD = 1
if the patient is diseased and D = 0 if the patient is non-diseased. Since
each test can be scored from 1 to J , we can define its ROC curve in two
3
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ways: (1) the non-parametric ROC curve based on the discrete sensitivity
and specificity values, and (2) the continuous ROC curve of a latent variable
underlying the observable ordinal data. In this paper, we focus on the non-
parametric ROC curve. To compute a discrete ROC curve from the ordinal
data, we vary the threshold for a positive test and then calculate J +1 pairs
of true positive rates (TPR) and false positive rates (FPR). Specifically, for
the kth test, if we define a positive test as one with Tk ≥ j, a corresponding
pair of TPR and FPR are
TPRk(j) = P (Tk ≥ j |D = 1), FPRk(j) = P (Tk ≥ j |D = 0),
respectively, for j = 1, · · · , J + 1. Here, TPRk(1) = FPRk(1) = 1, and
TPRk(J + 1) = FPRk(J + 1) = 0. A discrete ROC curve is defined as a
discrete function of (FPRk(j), TPRk(j)), j = 1, · · · , J + 1. By connecting
coordinates with linear lines, we obtain the non-parametric ROC curve. Us-
ing the trapezoidal rule for integration (Bamber, 1975), we can obtain the
area under the non-parametric ROC curve of the kth test as follows
Ak =
J−1∑
j=1
[
P (Tk = j |D = 0)
J∑
l=j+1
P (Tk = l |D = 1)
]
+
1
2
J∑
j=1
P (Tk = j |D = 0)P (Tk = j |D = 1)
(1)
If we define φ0kj = P (Tk = j |D = 0) and φ1kj = P (Tk = j |D =
1), we can express the ROC curve and its area as functions of φ0kj and
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φ1kj. Note that the coordinates of the non-parametric ROC curve of Tk are
(FPRk(j), TPRk(j)), which are related to the parameters φ1jl and φ2jl in
the following form:
FPRk(j) =
J∑
l=j
φ0kl, TPRk(j) =
J∑
l=j
φ1kl. (2)
Similarly we can show the area under the ROC curve for the kth test can be
written as follows:
Ak =
J−1∑
j=1
[
φ0kj
J∑
l=j+1
φ1kl
]
+
1
2
J∑
j=1
φ0kjφ1kj. (3)
We wish to formulate the likelihood for this particular problem in such
a way that φ0kj and φ1kj play central roles. Specifically, we wish to be able
to find maximum likelihood estimates (MLEs) for these parameters and to
employ them in order to calculate MLEs for the ROC curve and its areas
under each of the K tests.
Let yikj be a binary variable such that yikj = 1 if the response of the
kth test is j for the ith patient and yijk = 0 otherwise, where i = 1, · · · , N ,
k = 1, · · · , K, and j = 1, · · · , J . Then we can construct a K × J binary
vector yi such that yi = (yi11, · · · , yi1J , · · · , yiK1, · · · , yiKJ). We will call yi
the test score vector for the ith patient. Also let us define the disease status
of the ith patient to be Di = 1 if the ith patient is diseased and Di = 0
if the ith patient is not diseased. Now let us define the likelihood function
5
Hosted by The Berkeley Electronic Press
gd(yi) = P (yi |Di = d) to be the conditional probability of ith patient’s test
score vector yi given their disease status Di = d. When assuming conditional
independence of the K tests, we can write that
gd(yi) =
K∏
k=1
J∏
j=1
[φdkj]
yikj , (4)
where φdkj = P (Tk = j|D = d). Here we employ the “1/0” property of the
vector yi to turn “on/off” the proper φdkj.
If we assume a Bernoulli distribution for disease status with pd = P (D =
d) for d = 0, 1, we obtain that the marginal likelihood contributed by the ith
patient has the following mixture form: P (yi) = p1g1(yi) + p0g0(yi). The
joint log-likelihood of all N patients is given by
l(p1,φ0,φ1) =
N∑
i=1
log[p0g0(yi) + p1g1(yi)], (5)
where p0 = 1 − p1, and φd represents the vector of conditional probabilities
(φd11, · · · , φd1J , · · · , φdK1, · · · , φdKJ) for d = 0, 1.
Our goal is to find maximum likelihood (ML) estimates for p1, φ0 =
(φ011, · · · , φ0KJ) and φ1 = (φ111, · · · , φ1KJ), subjecting to the normalizing
conditions
∑J
j=1 φdkj = 1 for d = 0, 1 and all k = 1, · · · , K. These are
precisely the parameters needed in order to estimate the ROC curves and
their respective areas for each of the K tests. Here we employ the EM
algorithm to find the ML estimates by treating D as missing data. Therefore
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our complete data consist of (y, D). The main advantage of the EM algorithm
over the directly maximizing the log-likelihood function (5) is that there is
an explicit solution in the M step for our non-parametric approach.
Let θ = (p1,φ0,φ1). Note that the complete-data log-likelihood is given
by
lc(θ) =
N∑
i=1
[Di log p1g1(yi) + (1−Di) log p0g0(yi)].
Let θ(t) denote the estimate of θ after the tth iteration of the EM algorithm.
• E step: The E step computes the conditional expectation of lc(θ) given
the observed data y and current parameter estimates θ = θ(t),
E(lc(θ) |y, θ = θ(t)) =
N∑
i=1
1∑
d=0
P (Di = d |yi,θ(t)) log pdgd(yi).
If we write
q
(t)
id = P (Di = d |yi, p(t)1 ,φ(t)0 ,φ(t)1 ),
and
g
(t)
d (yi) =
K∏
k=1
J∏
j=1
[φ
(t)
dkj]
yikj ,
we can show that
q
(t)
id =
p
(t)
d g
(t)
d (yi)
p
(t)
0 g
(t)
0 (yi) + p
(t)
1 g
(t)
1 (yi)
, (6)
7
Hosted by The Berkeley Electronic Press
and
E(lc(θ) |y,θ = θ(t)) =
N∑
i=1
1∑
d=0
q
(t)
id log gd(yi). (7)
• M step: The M step finds the updated estimate θ(t+1) for θ by max-
imizing E(lc(θ) |y,θ = θ(t)) in (7). We can show that θ(t+1) has the
following explicit expression:
p
(t+1)
1 =
1
N
N∑
i=1
q
(t)
i1 , (8)
and
φ
(t+1)
dkj =
∑N
i=1 q
(t)
id yikj∑N
i=1 q
(t)
id
. (9)
It is helpful to note that
p
(t+1)
0 φ
(t+1)
0kj + p
(t+1)
1 φ
(t+1)
1kj =
1
N
N∑
i=1
[(q
(t+1)
i0 + q
(t+1)
i1 )yikj] =
1
N
N∑
i=1
yikj ≡ y¯∗kj.(10)
Though not required for the initial parameter estimates, the above con-
dition will hold after any iteration and thus will hold for the eventual MLEs,
θˆ. Therefore this is a necessary condition for any set of MLEs under our
non-parametric model. We call the condition pˆ0φˆ0kj+ pˆ1φˆ1kj = y¯∗kj the MLE
Mixture Condition. Due to this property we have just reduced the effective
parameter space almost in half.
We obtain the estimated covariance matrix for θ using the Fisher infor-
mation matrix, which is given in Appendix A.
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2.2 Equal conditional probability solution
Notice that if one selects the initial parameters such that φ0kj = φ1kj for
all k and j then g
(t=0)
0 (yi) = g
(t=0)
1 (yi). By equation (6), q
(t)
i1 does not depend
on data y and remains constant for all patients i = 1, · · · , N . So during each
iteration p
(t+1)
1 = p
(t)
1 = · · · = p(0)1 , and we find that the prevalence rate p1
stays fixed to whatever value was selected for its initial estimate. It can also
be seen that φ
(t+1)
dkj =
1
N
∑N
i=1 yikj = y¯∗kj for d = 0, 1 and all 1 ≤ k ≤ K and
1 ≤ j ≤ J . Thus given any initial parameters such that φ0kj = φ1kj for all k
and j and any p
(0)
1 the iterative procedure will stop after just one iteration.
It can be shown that for every such case the log-likelihood score function
is zero, and thus each such case is a local log-likelihood maximum. Thus
we are assured of the existence of an infinite number of local log-likelihood
maxima. We hope this set of local maxima do not comprise all local maxima.
For then the global maxima would be one such case and not only would p1
be indeterminate, but we would conclude that φ0kj = φ1kj for all k and j.
It implies that each test is worthless for determining disease status since
for each outcome of any test for a patient is equally likely regardless of
disease status. Obviously this problem is sensitive to the selection of the
initial parameter estimates and we can see which ones it would probably be
worth avoiding. Therefore in seeking the global maximum using the proposed
non-parametric approach, we make the following recommendations: 1) avoid
equal φ0kj = φ1kj for all k and j, this should not be a difficult decision
as in practice certain asymmetry in the test scores are often obvious; 2)
9
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try a set of reasonable initial parameter estimates, and compare the local
log-likelihood maxima obtained; 3) reasonable initial values can be obtained
from similar studies with known disease status; 4) study the likelihood surface
using exploratory and simulation techniques such as the Stochastic EM we
devise in our simulation study, see Section 4 for more details.
2.3 Invariance property of log-likelihood function
Upon looking at the log-likelihood equation (5) one can see that this equa-
tion is invariant to the re-labeling of the parameter sets (p0,φ0, p1,φ1) to
(p1,φ1, p0,φ0). This implies that there can never exist a unique global max-
imum likelihood solution, since any such maximum, say (pˆ1, φˆ0, φˆ1) would
imply the existence of a ”mirror” maximum of equal likelihood at ((1 −
pˆ1), φˆ1, φˆ0). Thus the best case is that we arrive at a presumed global maxi-
mum by the use of the EM algorithm, and can distinguish between these two
possibilities by a reasonable ordering of the prevalence rate pˆ1 or pˆ0 or by
the plausibility of the resulting areas under the K ROC curves. The latter
case may be possible since the area under any test k, say Ak(φ0k•,φ1k•), is
equal to 1 − Ak(φ1k•,φ0k•) where φdk• = (φdk1, . . . , φdkJ). For a proof, see
Appendix B. Therefore, for any credible test we could presumably choose the
global maximum for which Ak > 0.5 for all k = 1, . . . , K if such a case exists.
10
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2.4 Sum of squared residuals
Let us look at the sum of squared residuals as defined by:
SS =
N∑
i=1
K∑
k=1
J∑
j=1
[yikj − E(yikj)]2 (11)
Since for any patient i E(yikj) = pˆ0φˆ0kj+pˆ1φˆ1kj, then by the MLE Mixture
Condition we find that E(yikj) = y¯∗kj. Thus at any local maximum and for
every iteration of the EM algorithm the sum of squared residuals remain
constant at the value:
SS =
N∑
i=1
K∑
k=1
J∑
j=1
[yikj − y¯∗kj]2 (12)
Thus at each iteration of the EM algorithm the parameters are being
updated in such a manner as to always increase the log-likelihood and mean-
while the sum of squared residuals remains fixed. Just as in the case of the
maximum likelihood criterion there are an infinite number of suitable choices
among the parameter set but for the case of the sum of squares there is no
way of distinguishing between the possible choices for a ”best” set.
3. Simulation Study
3.1 Finite sample performance
To assess the performance of the proposed likelihood-based approach in
finite samples, we carried out simulation studies under different ROC curve
11
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conditions. In the simulations we assessed the bias and mean squared error
(MSE) of our estimators. We focused on the prevalence p1 and the area
under curve (AUC). We chose sample size to be N = 118 and N = 500, and
the number of tests to be K = 7, as our real data set. In our simulation
studies we constructed the experiments by varying the parameters φ0kj and
φ1kj in such a manner that A1, · · · , A7 took different values. We also took
the prevalence rate p1 to be 0.5, 0.7, and 0.9.
Tables 1 and 2 summarize the bias and MSE of the estimated ROC areas
for equal ROC curve areas (A1 = · · · = A7 = A), with A = 0.7, 0.8 and 0.9,
and the sample size N is 118 and 500, respectively.
[Table 1 about here.]
[Table 2 about here.]
Tables 3 and 4 summarize the bias and MSE of the estimated ROC curve
areas for unequal ROC curve areas (A1 = 0.9, A2 = 0.87, A3 = 0.83, A4 =
0.80, A5 = 0.77, A6 = 0.73, A7 = 0.7) when the sample size N is 118 and 500,
respectively.
[Table 3 about here.]
[Table 4 about here.]
From the results in Tables 1-4 we see that the proposed method yields
ML estimates for ROC curves with small bias and MSE regardless the true
12
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ROC curve areas. In general, the higher the areas under ROC curves are,
the smaller their bias and MSEs. In other words, the estimators perform
better when the tests distinguish the disease status better. Hence, the pro-
posed method has good finite sample size performance under the conditional
independence assumption.
3.2 Comparison to a parametric approach
Although the main purpose of this paper is to introduce a non-parametric
approach to the ROC curve estimation without gold standard, it is of inter-
est to compare it with existing parametric approaches. Unfortunately most
published literature has been on the problem of hypothesis testing, not on es-
timation based on parametric models ( Hui and Zhou, 1998; Qu and Hadgu,
1998). Therefore, for our simulation studies, we had to extend the classic
binormal model to the situation where the patient disease status is missing.
Following Diebolt and Ip (1996) we adapted the ROCFIT program (Metz
et al., 1994) to allow missing indicator of disease status. A stochastic step is
added to impute the missing disease indicator D from its conditional density
given observation y and current parameter estimate φ(m) of parameter φ.
Since this imputation is based on all our current information, and hence pro-
vides us with a plausible pseudo-complete sample. Once we have a pseudo-
complete sample, we can directly maximize its log-likelihood to obtain an
updated MLE φ(m+1) using the standard ROCFIT program. This whole
process is iterated. This is the stochastic EM (SEM) algorithm introduced
13
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by Celeux and Diebolt (1985). Under mild conditions the SEM algorithm
generates a Markov chain {φ(m)} which converges to a stationary distribu-
tion pi(·). The stationary distribution is approximately centered at the MLE
of φ thus provides an alternative for the maximum likelihood estimation.
Standard errors of MLE can be easily derived from the simulated samples as
well (Diebolt and Ip, 1996). Due to the stochastic nature of SEM algorithm,
unlike the EM algorithm the log-likelihood does not decrease monotonically,
and the convergence of the Markov chain has to be monitored using conver-
gence diagnostics. As noted by Diebolt and Ip (1996), in most situations
convergence is reached reasonably fast. See Biernacki et al. (2003) for more
on stopping criteria. For our simulation, we used 400 iterations with 200 as
burn-in.
Table 5 lists the MLEs from both parametric and non-parametric ap-
proaches when the data are actual binormal. The data were generated from
two overlapping Gaussian distributions with different degree of separation
(A1 = 0.95, A2 = 0.90, A3 = 0.90, A4 = 0.85, A5 = 0.85, A6 = 0.80, A7 =
0.75), with various ratios of SDs of distributions for the non-diseased to dis-
eased, and various decision thresholds. It appears the results from our non-
parametric approach are quite comparable to those from parametric models.
The validity of the parametric and non-parametric methods relies on one
common assumption and some unique assumptions. Both the methods make
the conditional independence assumption. While the non-parametric method
makes the irreducibility assumption, the parametric method makes paramet-
14
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ric assumptions on the distributions of latent variables.
But the non-parametric approach has additional advantages: it is poten-
tially more robust since no distributional assumptions are required, and it is
easier to implement when there is no gold standard.
[Table 5 about here.]
Table 6 lists the results from a simulation study where the true para-
metric distributions are not binormal. The distribution for non-diseased
subjects was chosen to be Gaussian, but the distribution for diseased sub-
jects was formed from a mixture of two Gaussian distributions to create
right-skewed bimodal distributions. Again the AUCs were fixed a priori,
with various ratios of SDs of component distributions for the non-diseased
to diseased subjects. It can be seen under such the setting, both approaches
perform worse than those in Table 5. The results from both non-parametric
approach and parametric approach are quite comparable. And for p1 = 0.9,
the non-parametric approach again appears to perform better, but for smaller
p1 parametric approach appears to perform better. It has been shown that
binormal model is quite robust to model mis-specification (Hajian-Tilaki,
Hanley, Joseph and Collet, 1997; Walsh, 1997), the close estimates of diag-
nostic accuracy (AUC) and the corresponding precision in our simulations
are consistent with the findings by those authors.
[Table 6 about here.]
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4. A Real Example
Holmquist, McMahan and Williams (1967) studied variability in detection
of carcinoma in situ of the Uterine Cervix among seven pathologists under
the study. These seven pathologists were all senior staff pathologists who
were involved in diagnoses of surgical pathologic specimens during 1963 at
Louisiana State University Medical Center. During the period July 1, 1964
through June 30, 1965, these seven pathologists independently evaluated and
classified lesions on each of the 118 randomly ordered slides into five category
ordinal-scale, ranging from 1 (negative) to 5 (invasive carcinoma) categories.
In this study, there was a clinical definition on carcinoma in situ of the
uterine cervix. However, due to technological limitations, diagnosis based on
the clinical definition was not available.
Landis and Koch (1977) assessed variability in detection of carcinoma
among the seven readers using agreement measures. However, the agreement
information cannot translated into the accuracy information. For example,
the seven readers might agree on the disease status of a patient, they all could
be wrong. In this section we apply the proposed method in Sections 2 to as-
sess the variability in the diagnostic accuracy of each reader in detecting the
carcinoma in situ of the uterine cervix, in terms of the empirical ROC curve
and its area under the curve. We summarize the estimated non-parametric
ROC curves for the seven readers in Figure 1, and the corresponding areas
under the ROC curves are 0.94, 0.92, 0.90, 0.93, 0.95, 0.87, and 0.98, re-
spectively. The estimated prevalence is 0.61. The estimated areas under the
16
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curves under binormal model assumption are 0.84, 0.83, 0.83, 0.86, 0.84, 0.84
and 0.85, respectively, the prevalence is estimated to be 0.65. The computa-
tion was carried out using the SEM algorithm discussed above. It appears the
parametric approach gave more conservative estimates of the test accuracy,
but the validity of the estimates relies on the binormal assumption and the
convergence of the Markov chain. The log-likelihood under non-parametric
MLEs is −779.23, whereas the log-likelihood under MLEs from the binormal
model is −841.15. The likelihood ratio test statistic is 123.84 with degrees of
freedom 14, larger than χ20.95,14 = 23.68, so the non-parametric model gives
significant better fit to the data than the binormal model.
[Figure 1 about here.]
5. Discussion
In this paper we have proposed a ML method for estimating the accuracy
of ordinal-scale diagnostic tests with the EM algorithm, based on a latent
class model. To avoid controversies on the use of a latent class model in
the problem of imperfect gold standard (Alonzo and Pepe, 1999;Hadgu and
Miller, 2001; Pepe and Alonzo, 2001), in this paper we assume that we
are dealing with clinical studies in which a gold standard exists but is not
available.
Our simulation result has shown the proposed estimators have good small
bias and mean squared error (MSE). However, the global ML estimate is
not unique; there is a ”mirror” solution. If (pˆ1, φˆ0, φˆ1) is ML estimates for
17
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(p1,φ0,φ1), (1 − pˆ1, φˆ1, φˆ0) is also ML estimates. This result is consistent
with the imperfect gold standard bias problem in binary-scale tests as ob-
served by Hui and Walter (1980). One additional complication in finding
a global ML estimate is that there are many local ML estimates. To over-
come this problem we recommend randomly perturbing the starting point,
or recomputing the ML estimates based on a set of plausible initial values.
An advantage with our proposed non-parametric ML approach is that
it does not require specific modeling assumptions, therefore it is likely to
be more robust. Another advantage is that there is explicit solution at the
M-step, so it is much easier to implement the corresponding EM algorithm.
Our simulation studies show that non-parametric estimates are comparable
to those from parametric models. But because the missing disease status, the
parametric likelihood involves complicated mixture form and differentiation,
which makes it harder to carry out the computation. Our experience also
suggests the computation for parametric models is more sensitive to initial
values and less stable when the tables are close to degeneracy.
The proposed non-parametric method requires the conditional indepen-
dence and irreducibility assumptions. One future research is to develop a
parametric ML method without assuming conditional independence. For ex-
ample, we may use a log-linear model without higher order interactions or a
random-effect latent class model as done in Hadgu and Qu (1998) and Qu
and Hadgu (1998).
18
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Appendix A
Expected Fisher’s Information Matrix
We summarize Expected Fisher’s information matrix of the log-likelihood
function in the following.
The Expected Fisher’s information matrix equals to
E
[
−∂
2l(p1,φ0,φ1)
∂(p1,φ0,φ1)
2
]
.
Here
E
[
−∂
2l(p1,φ0,φ1)
∂p21
]
=
J∑
j1=1
· · ·
J∑
jK=1
[
E[n(j1, · · · , jK)]
(
pi1(j1, · · · , jK)
p1
− pi0(j1, · · · , jK)
p0
)2]
,
E
[
−∂
2l(p1,φ0,φ1)
∂p1∂φ0kj
]
=
J∑
j1=1
· · ·
J∑
jk−1=1
J∑
jk+1=1
· · ·
J∑
jK=1
[
E[n(jk = j)]
(
pi0(jk = j)pi1(jk = j)
p0p1φ0kj
)
−E[n(jk = J)]
(
pi0(jk = J)pi1(jk = J)
p0p1φ0kJ
)]
,
E
[
−∂
2l(p1,φ0,φ1)
∂p1∂φ1kj
]
=
J∑
j1=1
· · ·
J∑
jk−1=1
J∑
jk+1=1
· · ·
J∑
jK=1
[
−E[n(jk = j)]
(
pi0(jk = j)pi1(jk = j)
p0p1φ1kj
)
+E[n(jk = J)]
(
pi0(jk = J)pi1(jk = J)
p0p1φ1kJ
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,
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and
E
[
−∂
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.
We can prove this using calculus and algebra. Since the proof is straight-
forward but requires tedious calculus and algebra operations, we omit the
proof.
Appendix B
Proof of Invariance Property of ROC Curve Areas
From the expression (3) on an ROC curve area, we obtain that
Ak(φ0k•,φ1k•) + Ak(φ1k•,φ0k•)
=
J−1∑
j=1
[
φ0kj
J∑
l=j+1
φ1kl
]
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1
2
J∑
j=1
φ0kjφ1kj +
J−1∑
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[
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J∑
j=l+1
φ0kj
]
+
1
2
J∑
j=1
φ1kjφ0kj
=
J−1∑
j=1
[
φ0kj
J∑
l=j+1
φ1kl
]
+
J−1∑
l=1
[
φ1kl
J∑
j=l+1
φ0kj
]
+
J∑
j=1
φ0kjφ1kj.
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Note that
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j=l+1
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φ1kl
Then we find
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where we have repeatedly used the fact
∑J
j=1 φ0kj =
∑J
j=1 φ1kj = 1.
Thus we conclude that
Ak(φ0k•,φ1k•) + Ak(φ1k•,φ0k•) = 1
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Figure 1. Estimated ROC curves for each of the seven pathologist based on
non-parametric model
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Table 1
Results From 500 Simulations With N=118, J=5, K=7 Under Various
Parameter Settings
True True Areas 0.7 0.7 0.7 0.7 0.7 0.7 0.7
Prevalence Statistic p1 A1 A2 A3 A4 A5 A6 A7
0.5 Bias -0.0186 -0.0127 -0.0109 -0.0140 -0.0135 -0.0094 -0.0142 -0.0164
MSE 0.0305 0.0089 0.0083 0.0095 0.0090 0.0082 0.0087 0.0091
0.7 Bias -0.1098 -0.0266 -0.0214 -0.0262 -0.0321 -0.0254 -0.0352 -0.0272
MSE 0.0497 0.0127 0.0109 0.0127 0.0121 0.0106 0.0117 0.0128
0.9 Bias -0.3398 -0.1065 -0.1021 -0.0960 -0.1082 -0.0980 -0.1059 -0.0983
MSE 0.1604 0.0277 0.0259 0.0241 0.0262 0.0235 0.0254 0.0240
True True Areas 0.8 0.8 0.8 0.8 0.8 0.8 0.8
Prevalence Statistic p1 A1 A2 A3 A4 A5 A6 A7
0.5 Bias -0.0067 0.0012 0.0008 -0.0042 0.0022 -0.0008 -0.0059 0.0007
MSE 0.0039 0.0024 0.0025 0.0025 0.0026 0.0024 0.0027 0.0025
0.7 Bias -0.0109 0.0000 -0.0057 -0.0035 -0.0041 -0.0037 -0.0079 0.0014
MSE 0.0042 0.0031 0.0032 0.0031 0.0031 0.0033 0.0033 0.0033
0.9 Bias -0.0947 -0.0593 -0.0595 -0.0596 -0.0615 -0.0602 -0.0605 -0.0543
MSE 0.0263 0.0170 0.0169 0.0169 0.0162 0.0159 0.0167 0.0157
True True Areas 0.9 0.9 0.9 0.9 0.9 0.9 0.9
Prevalence Statistic p1 A1 A2 A3 A4 A5 A6 A7
0.5 Bias 0.0022 0.0007 0.0008 0.0007 0.0005 0.0005 -0.0001 0.0006
MSE 0.0023 0.0007 0.0007 0.0007 0.0006 0.0007 0.0007 0.0007
0.7 Bias 0.0021 0.0009 0.0001 0.0000 0.0013 0.0000 -0.0003 0.0001
MSE 0.0021 0.0009 0.0008 0.0008 0.0009 0.0008 0.0009 0.0008
0.9 Bias 0.0019 -0.0004 -0.0019 -0.0002 -0.0023 -0.0011 0.0008 -0.0042
MSE 0.0007 0.0024 0.0023 0.0021 0.0026 0.0024 0.0023 0.0023
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Table 2
Results From 500 Simulations With N=500, J=5, K=7 Under Various
Parameter Settings
true True Areas 0.7 0.7 0.7 0.7 0.7 0.7 0.7
Prevalence Statistic p1 A1 A2 A3 A4 A5 A6 A7
0.5 Bias -0.0003 0.0003 0.0010 0.0021 0.0015 0.0004 0.0007 0.0008
MSE 0.0065 0.0013 0.0015 0.0014 0.0015 0.0014 0.0014 0.0013
0.7 Bias 0.0006 0.0027 0.0051 0.0005 0.0040 -0.0015 0.0013 0.0047
MSE 0.0066 0.0018 0.0019 0.0021 0.0022 0.0020 0.0021 0.0018
0.9 Bias -0.1308 -0.0371 -0.0452 -0.0360 -0.0364 -0.0336 -0.0360 -0.0325
MSE 0.0818 0.0125 0.0138 0.0116 0.0120 0.0124 0.0125 0.0123
True True Areas 0.8 0.8 0.8 0.8 0.8 0.8 0.8
Prevalence Statistic p1 A1 A2 A3 A4 A5 A6 A7
0.5 Bias 0.0001 -0.0017 0.0010 0.0006 -0.0005 -0.0002 -0.0003 0.0007
MSE 0.0008 0.0005 0.0005 0.0005 0.0005 0.0005 0.0005 0.0005
0.7 Bias 0.0005 -0.0017 0.0013 0.0006 -0.0005 0.0012 -0.0005 0.0016
MSE 0.0007 0.0006 0.0007 0.0006 0.0006 0.0007 0.0007 0.0006
0.9 Bias -0.0022 -0.0019 0.0026 0.0031 -0.0006 -0.0001 -0.0046 0.0009
MSE 0.0004 0.0020 0.0019 0.0018 0.0020 0.0021 0.0021 0.0019
True True Areas 0.9 0.9 0.9 0.9 0.9 0.9 0.9
Prevalence Statistic p1 A1 A2 A3 A4 A5 A6 A7
0.5 Bias 0.0014 -0.0009 0.0007 0.0000 -0.0008 -0.0005 -0.0004 0.0001
MSE 0.0005 0.0002 0.0002 0.0002 0.0002 0.0002 0.0002 0.0002
0.7 Bias 0.0018 -0.0006 0.0006 0.0001 -0.0007 0.0004 0.0002 0.0011
MSE 0.0004 0.0002 0.0002 0.0002 0.0002 0.0002 0.0002 0.0002
0.9 Bias -0.0011 0.0011 -0.0002 0.0007 -0.0008 -0.0001 -0.0006 0.0007
MSE 0.0002 0.0004 0.0004 0.0004 0.0005 0.0004 0.0005 0.0004
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Table 3
Results From 500 Simulations With N=118, J=5, K=7 Under Various
Parameter Settings
True True Areas 0.90 0.87 0.83 0.80 0.77 0.73 0.70
Prevalence Statistic p1 A1 A2 A3 A4 A5 A6 A7
0.5 Bias -0.0009 -0.0045 -0.0059 0.0052 0.0039 0.0049 0.0007 0.0042
MSE 0.0027 0.0009 0.0012 0.0017 0.0019 0.0022 0.0025 0.0027
0.7 Bias -0.0053 -0.0057 -0.0082 0.0044 0.0074 0.0072 0.0037 0.0032
MSE 0.0029 0.0012 0.0015 0.0023 0.0025 0.0025 0.0032 0.0039
0.9 Bias -0.0389 -0.0500 -0.0515 -0.0181 -0.0181 -0.0087 -0.0078 -0.0055
MSE 0.0082 0.0124 0.0114 0.0085 0.0102 0.0088 0.0088 0.0096
33
Hosted by The Berkeley Electronic Press
Table 4
Results From 500 Simulations With N=500, J=5, K=7 Under Various
Parameter Settings
True True Areas 0.90 0.87 0.83 0.80 0.77 0.73 0.70
True Prevalence Statistic p1 A1 A2 A3 A4 A5 A6 A7
0.5 Bias 0.0018 -0.0014 0.0000 0.0016 -0.0001 0.0004 0.0001 0.0006
MSE 0.0006 0.0002 0.0002 0.0004 0.0004 0.0005 0.0005 0.0005
0.7 Bias 0.0015 -0.0013 0.0001 0.0019 0.0002 0.0016 0.0004 0.0017
MSE 0.0005 0.0002 0.0003 0.0005 0.0006 0.0006 0.0007 0.0006
0.9 Bias 0.0000 -0.0022 0.0005 0.0058 0.0025 0.0037 -0.0008 0.0040
MSE 0.0003 0.0007 0.0009 0.0011 0.0015 0.0016 0.0019 0.0017
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Table 5
Results From 500 Simulations With N=118, J=5, K=7 Under BiNormal
Models
True True Areas 0.95 0.90 0.90 0.85 0.85 0.80 0.75
Prevalence Statistic Model∗ p1 A1 A2 A3 A4 A5 A6 A7
0.5 Bias P 0.0034 -0.0046 -0.0024 -0.0070 0.0002 0.0009 0.0002 -0.0014
NP -0.0008 -0.0124 -0.0118 -0.0092 -0.0046 -0.0059 0.0038 0.0112
MSE P 0.0023 0.0005 0.0012 0.0011 0.0012 0.0014 0.0022 0.0029
NP 0.0023 0.0007 0.0011 0.0011 0.0014 0.0015 0.0019 0.0020
0.7 Bias P -0.0041 -0.0119 -0.0388 -0.0507 0.0103 0.0017 -0.0040 -0.0271
NP -0.0064 -0.0106 -0.0125 -0.0104 -0.0074 -0.0077 0.0038 0.0141
MSE P 0.0017 0.0004 0.0026 0.0037 0.0010 0.0014 0.0017 0.0037
NP 0.0020 0.0009 0.0013 0.0012 0.0014 0.0013 0.0014 0.0021
0.9 Bias P -0.0205 -0.0663 -0.0736 -0.0649 -0.0494 -0.0346 -0.0569 -0.0497
NP -0.0143 -0.0401 -0.0316 -0.0295 -0.0205 -0.0196 -0.0057 0.0022
MSE P 0.0012 0.0064 0.0091 0.0065 0.0074 0.0039 0.0067 0.0071
NP 0.0016 0.0069 0.0054 0.0054 0.0044 0.0038 0.0036 0.0042
∗ P = parametric model; NP = non-parametric model.
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Table 6
Results From 500 Simulations With N=118, J=5, K=7 Under
Non-BiNormal Models
True True Areas 0.95 0.90 0.90 0.85 0.85 0.80 0.75
Prevalence Statistic Model∗ p1 A1 A2 A3 A4 A5 A6 A7
0.5 Bias P 0.0020 -0.0113 -0.0053 -0.0054 -0.0041 0.0024 0.0019 0.0012
NP -0.0039 -0.0118 -0.0117 -0.0127 -0.0070 -0.0043 0.0011 0.0149
MSE P 0.0026 0.0005 0.0011 0.0008 0.0015 0.0018 0.0025 0.0021
NP 0.0021 0.0007 0.0011 0.0012 0.0015 0.0015 0.0018 0.0026
0.7 Bias P -0.0033 -0.0107 -0.0083 -0.0074 -0.0031 -0.0023 -0.0001 0.0005
NP -0.0006 -0.0122 -0.0136 -0.0099 -0.0066 -0.0047 -0.0018 0.0123
MSE P 0.0025 0.0005 0.0010 0.0009 0.0013 0.0016 0.0021 0.0017
NP 0.0016 0.0008 0.0013 0.0013 0.0015 0.0014 0.0018 0.0022
0.9 Bias P -0.0147 -0.0566 -0.0416 -0.0318 -0.0363 -0.0361 -0.0186 -0.0096
NP -0.0149 -0.0297 -0.0298 -0.0260 -0.0234 -0.0138 -0.0052 0.0001
MSE P 0.0008 0.0043 0.0036 0.0026 0.0035 0.0033 0.0028 0.0041
NP 0.0012 0.0043 0.0046 0.0040 0.0042 0.0029 0.0040 0.0041
∗ P = parametric model; NP = non-parametric model.
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